A detailed history of Cable Hill Partners, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Cable Hill Partners, LLC holds 3,411 shares of AZN stock, worth $226,149. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,411
Previous 3,482 2.04%
Holding current value
$226,149
Previous $271,000 2.21%
% of portfolio
0.03%
Previous 0.03%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$76.67 - $87.62 $5,443 - $6,221
-71 Reduced 2.04%
3,411 $265,000
Q2 2024

Jul 22, 2024

BUY
$66.81 - $80.83 $232,632 - $281,450
3,482 New
3,482 $271,000
Q3 2023

Oct 27, 2023

BUY
$64.85 - $71.7 $198,181 - $219,115
3,056 New
3,056 $206,000
Q1 2023

May 04, 2023

SELL
$63.15 - $71.6 $58,098 - $65,872
-920 Reduced 23.6%
2,979 $206,000
Q4 2022

Feb 06, 2023

BUY
$54.21 - $70.44 $211,364 - $274,645
3,899 New
3,899 $264,000
Q2 2019

Aug 06, 2019

SELL
$37.28 - $41.68 $209,513 - $234,241
-5,620 Closed
0 $0
Q4 2018

Feb 12, 2019

SELL
$36.86 - $41.49 $1,290 - $1,452
-35 Reduced 0.62%
5,620 $214,000
Q3 2018

Nov 14, 2018

SELL
$34.76 - $39.72 $1,564 - $1,787
-45 Reduced 0.79%
5,655 $224,000
Q1 2018

Apr 20, 2018

SELL
$32.97 - $36.63 $2,307 - $2,564
-70 Reduced 1.21%
5,700 $201,000
Q4 2017

Feb 22, 2018

SELL
$32.09 - $34.78 $31,095 - $33,701
-969 Reduced 14.38%
5,770 $205,000
Q3 2017

Oct 27, 2017

BUY
$28.96 - $34.0 $186,618 - $219,096
6,444 Added 2184.41%
6,739 $228,000
Q2 2017

Aug 14, 2017

BUY
N/A
295
295 $10,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $205B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Cable Hill Partners, LLC Portfolio

Follow Cable Hill Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cable Hill Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cable Hill Partners, LLC with notifications on news.